Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Atrial Fibrillation and Dapagliflozin Efficacy in Patients With Preserved or Mildly Reduced Ejection Fraction

Published:2022-11 Issue:18 Volume:80 Page:1705-1717
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Butt Jawad H.,Kondo Toru^ORCID,Jhund Pardeep S.,Comin-Colet Josep,de Boer Rudolf A.,Desai Akshai S.,Hernandez Adrian F.,Inzucchi Silvio E.,Janssens Stefan P.,Kosiborod Mikhail N.,Lam Carolyn S.P.,Langkilde Anna Maria,Lindholm Daniel,Martinez Felipe,Petersson Magnus,Shah Sanjiv J.,Thierer Jorge,Vaduganathan Muthiah,Verma Subodh,Wilderäng Ulrica,Claggett Brian L.,Solomon Scott D.,McMurray John J.V.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry;Zafrir;Eur Heart J,2018

2. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction;Sartipy;J Am Coll Cardiol HF,2017

3. Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins;Kotecha;J Am Coll Cardiol,2016

4. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program;Olsson;J Am Coll Cardiol,2006

5. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Update in Heart Failure with Preserved Ejection Fraction;Current Heart Failure Reports;2024-09-03

2. Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction;Journal of the American College of Cardiology;2024-08

3. Impact of Sodium-glucose Cotransporter 2 Inhibitor on Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure;Heart Rhythm;2024-08

4. Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152 059 patients;European Heart Journal - Quality of Care and Clinical Outcomes;2024-07-22

5. Catheter‐based ablation to improve outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction: Rationale and design of the CABA‐HFPEF‐DZHK27 trial;European Journal of Heart Failure;2024-07-18